BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24891221)

  • 1. T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol.
    Timmermans AJ; de Gooijer CJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Head Neck; 2015 Oct; 37(10):1495-503. PubMed ID: 24891221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
    Timmermans AJ; van Dijk BA; Overbeek LI; van Velthuysen ML; van Tinteren H; Hilgers FJ; van den Brekel MW
    Head Neck; 2016 Apr; 38 Suppl 1():E1247-55. PubMed ID: 26315454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
    Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
    J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
    Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
    Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Vengalil S; Giuliani ME; Huang SH; McNiven A; Song Y; Xu W; Chan B; Hope A; Cho J; Bayley A; Ringash J; Goldstein D; Razak A; Irish J; Gilbert R; Gullane P; Waldron J; Kim J; O'Sullivan B
    Head Neck; 2016 Apr; 38 Suppl 1():E2035-40. PubMed ID: 26828197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database.
    Bates JE; Amdur RJ; Morris CM; Hitchcock KE; Dziegielewski PT; Boyce BJ; Silver NL; Shaw C; Mendenhall WM
    Am J Clin Oncol; 2019 Jun; 42(6):527-533. PubMed ID: 31136370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    Dyckhoff G; Plinkert PK; Ramroth H
    BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
    Chen AY; Fedewa S; Zhu J
    Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
    Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
    Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of combined treatment of patients with locally advanced laryngeal cancer using preoperative chemoradiotherapy].
    Kurpeshev OK; Andreev VG; Pankratov VA; Gulidov IA; Orlova AV; Lebedeva TV
    Vopr Onkol; 2015; 61(6):956-9. PubMed ID: 26995986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.
    Timmermans AJ; Lange CA; de Bois JA; van Werkhoven E; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Laryngoscope; 2016 Feb; 126(2):E60-7. PubMed ID: 26333005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
    Al-Mamgani A; Tans L; van Rooij P; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.